Novartis Institutes for BioMedical Research-San Diego, La Jolla, CA, United States of America.
Novartis Institutes for BioMedical Research-Cambridge, Cambridge, MA, United States of America.
PLoS One. 2022 Nov 21;17(11):e0277937. doi: 10.1371/journal.pone.0277937. eCollection 2022.
The importance of human cell-based in vitro tools to drug development that are robust, accurate, and predictive cannot be understated. There has been significant effort in recent years to develop such platforms, with increased interest in 3D models that can recapitulate key aspects of biology that 2D models might not be able to deliver. We describe the development of a 3D human cell-based in vitro assay for the investigation of nephrotoxicity, using RPTEC-TERT1 cells. These RPTEC-TERT1 proximal tubule organoids 'tubuloids' demonstrate marked differences in physiologically relevant morphology compared to 2D monolayer cells, increased sensitivity to nephrotoxins observable via secreted protein, and with a higher degree of similarity to native human kidney tissue. Finally, tubuloids incubated with nephrotoxins demonstrate altered Na+/K+-ATPase signal intensity, a potential avenue for a high-throughput, translatable nephrotoxicity assay.
不可低估将人类基于细胞的体外工具应用于药物开发的重要性,这些工具需要具备稳健、准确和可预测的特点。近年来,人们已经投入了大量精力来开发此类平台,并且对能够再现 2D 模型可能无法提供的生物学关键方面的 3D 模型产生了浓厚的兴趣。我们描述了一种用于研究肾毒性的 3D 人类基于细胞的体外分析方法,该方法使用 RPTEC-TERT1 细胞。与 2D 单层细胞相比,这些 RPTEC-TERT1 近端肾小管类器官“小管”在生理相关形态方面表现出明显的差异,通过分泌蛋白观察到对肾毒物的敏感性增加,并且与天然人肾组织的相似性更高。最后,用肾毒物孵育的小管显示出 Na+/K+-ATPase 信号强度的改变,这可能是高通量、可转化的肾毒性分析的一个途径。